139 related articles for article (PubMed ID: 12361850)
1. Tripeptidyl peptidase-I is essential for the degradation of sulphated cholecystokinin-8 (CCK-8S) by mouse brain lysosomes.
Warburton MJ; Bernardini F
Neurosci Lett; 2002 Oct; 331(2):99-102. PubMed ID: 12361850
[TBL] [Abstract][Full Text] [Related]
2. Lysosomal degradation of cholecystokinin-(29-33)-amide in mouse brain is dependent on tripeptidyl peptidase-I: implications for the degradation and storage of peptides in classical late-infantile neuronal ceroid lipofuscinosis.
Bernardini F; Warburton MJ
Biochem J; 2002 Sep; 366(Pt 2):521-9. PubMed ID: 12038963
[TBL] [Abstract][Full Text] [Related]
3. Tripeptidyl peptidase I, the late infantile neuronal ceroid lipofuscinosis gene product, initiates the lysosomal degradation of subunit c of ATP synthase.
Ezaki J; Takeda-Ezaki M; Kominami E
J Biochem; 2000 Sep; 128(3):509-16. PubMed ID: 10965052
[TBL] [Abstract][Full Text] [Related]
4. The lysosomal degradation of neuromedin B is dependent on tripeptidyl peptidase-I: evidence for the impairment of neuropeptide degradation in late-infantile neuronal ceroid lipofuscinosis.
Kopan S; Sivasubramaniam U; Warburton MJ
Biochem Biophys Res Commun; 2004 Jun; 319(1):58-65. PubMed ID: 15158442
[TBL] [Abstract][Full Text] [Related]
5. The specificity of lysosomal tripeptidyl peptidase-I determined by its action on angiotensin-II analogues.
Warburton MJ; Bernardini F
FEBS Lett; 2001 Jul; 500(3):145-8. PubMed ID: 11445074
[TBL] [Abstract][Full Text] [Related]
6. Classical late infantile neuronal ceroid lipofuscinosis fibroblasts are deficient in lysosomal tripeptidyl peptidase I.
Vines DJ; Warburton MJ
FEBS Lett; 1999 Jan; 443(2):131-5. PubMed ID: 9989590
[TBL] [Abstract][Full Text] [Related]
7. Tripeptidyl-peptidase I in neuronal ceroid lipofuscinoses and other lysosomal storage disorders.
Wisniewski KE; Kida E; Walus M; Wujek P; Kaczmarski W; Golabek AA
Eur J Paediatr Neurol; 2001; 5 Suppl A():73-9. PubMed ID: 11589013
[TBL] [Abstract][Full Text] [Related]
8. Glycosaminoglycans modulate activation, activity, and stability of tripeptidyl-peptidase I in vitro and in vivo.
Golabek AA; Walus M; Wisniewski KE; Kida E
J Biol Chem; 2005 Mar; 280(9):7550-61. PubMed ID: 15582991
[TBL] [Abstract][Full Text] [Related]
9. Detection of tripeptidyl peptidase I activity in living cells by fluorogenic substrates.
Steinfeld R; Fuhrmann JC; Gärtner J
J Histochem Cytochem; 2006 Sep; 54(9):991-6. PubMed ID: 16782851
[TBL] [Abstract][Full Text] [Related]
10. [Tripeptidyl-peptidase I--distribution, biogenesis, and mechanisms of activation].
Gołabek AA
Postepy Biochem; 2006; 52(1):16-23. PubMed ID: 16869297
[TBL] [Abstract][Full Text] [Related]
11. Biosynthesis, glycosylation, and enzymatic processing in vivo of human tripeptidyl-peptidase I.
Golabek AA; Kida E; Walus M; Wujek P; Mehta P; Wisniewski KE
J Biol Chem; 2003 Feb; 278(9):7135-45. PubMed ID: 12488460
[TBL] [Abstract][Full Text] [Related]
12. Tripeptidyl peptidases: enzymes that count.
Tomkinson B
Trends Biochem Sci; 1999 Sep; 24(9):355-9. PubMed ID: 10470035
[TBL] [Abstract][Full Text] [Related]
13. Distribution of tripeptidyl peptidase I in human tissues under normal and pathological conditions.
Kida E; Golabek AA; Walus M; Wujek P; Kaczmarski W; Wisniewski KE
J Neuropathol Exp Neurol; 2001 Mar; 60(3):280-92. PubMed ID: 11245212
[TBL] [Abstract][Full Text] [Related]
14. The substrate range of tripeptidyl-peptidase I.
Bernardini F; Warburton MJ
Eur J Paediatr Neurol; 2001; 5 Suppl A():69-72. PubMed ID: 11589011
[TBL] [Abstract][Full Text] [Related]
15. The expression of tripeptidyl peptidase I in various tissues of rats and mice.
Koike M; Shibata M; Ohsawa Y; Kametaka S; Waguri S; Kominami E; Uchiyama Y
Arch Histol Cytol; 2002 Aug; 65(3):219-32. PubMed ID: 12389661
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing exopeptidase inhibitors.
Ganellin CR; Bishop PB; Bambal RB; Chan SM; Leblond B; Moore AN; Zhao L; Bourgeat P; Rose C; Vargas F; Schwartz JC
J Med Chem; 2005 Nov; 48(23):7333-42. PubMed ID: 16279793
[TBL] [Abstract][Full Text] [Related]
17. Prosegment of tripeptidyl peptidase I is a potent, slow-binding inhibitor of its cognate enzyme.
Golabek AA; Dolzhanskaya N; Walus M; Wisniewski KE; Kida E
J Biol Chem; 2008 Jun; 283(24):16497-504. PubMed ID: 18411270
[TBL] [Abstract][Full Text] [Related]
18. Mutations in classical late infantile neuronal ceroid lipofuscinosis disrupt transport of tripeptidyl-peptidase I to lysosomes.
Steinfeld R; Steinke HB; Isbrandt D; Kohlschütter A; Gärtner J
Hum Mol Genet; 2004 Oct; 13(20):2483-91. PubMed ID: 15317752
[TBL] [Abstract][Full Text] [Related]
19. Characterization of endopeptidase activity of tripeptidyl peptidase-I/CLN2 protein which is deficient in classical late infantile neuronal ceroid lipofuscinosis.
Ezaki J; Takeda-Ezaki M; Oda K; Kominami E
Biochem Biophys Res Commun; 2000 Feb; 268(3):904-8. PubMed ID: 10679303
[TBL] [Abstract][Full Text] [Related]
20. N-glycosylation is crucial for folding, trafficking, and stability of human tripeptidyl-peptidase I.
Wujek P; Kida E; Walus M; Wisniewski KE; Golabek AA
J Biol Chem; 2004 Mar; 279(13):12827-39. PubMed ID: 14702339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]